Market Tracker

09/19 6:35pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

11.50
Data as of Sep 19
 -0.45 / -3.77%
Today’s Change
2.26
Today|||52-Week Range
13.80
+246.49%
Year-to-Date

Today’s Trading

Previous close11.95
Today’s open12.01
Day’s range11.42 - 12.06
Volume9,558,053
Average volume (3 months)5,840,375
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+1.56%
Earnings growth (this year)-13.19%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book7.56

Competitors

 Today’s
change
Today’s
% change
INSYInsys Therapeutics I...-0.36-1.06%
PTCTPTC Therapeutics Inc+0.83+2.07%
NBIXNeurocrine Bioscienc...-0.37-2.26%
PDLIPDL BioPharma Inc+0.14+1.77%
Data as of 3:59pm ET, 09/19/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$58.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Head-Investor Relations
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts